Fidelity Investments’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.1K Buy
3,561
+1,270
+55% +$20.3K ﹤0.01% 4119
2025
Q4
$17.6K Buy
2,291
+819
+56% +$6.46K ﹤0.01% 4519
2025
Q3
$10.9K Buy
1,472
+1,238
+529% +$6.34K ﹤0.01% 4584
2025
Q2
$937 Buy
234
+229
+4,580% +$833 ﹤0.01% 4975
2025
Q1
$17 Hold
5
﹤0.01% 5229
2024
Q4
$29 Sell
5
-5
-50% -$37 ﹤0.01% 5287
2024
Q3
$51 Sell
10
-43
-81% -$154 ﹤0.01% 5174
2024
Q2
$96 Buy
53
+36
+212% +$67 ﹤0.01% 4978
2024
Q1
$30 Buy
+17
New +$36 ﹤0.01% 5108
2023
Q4
Sell
-1,101
Closed -$1.61K 5471
2023
Q3
$1.61K Buy
+1,101
New +$2.33K ﹤0.01% 4586
2020
Q2
Sell
-400
Closed -$1K 3657
2020
Q1
$1K Buy
+400
New +$1.62K ﹤0.01% 3473
2019
Q4
Sell
-426,656
Closed -$1.28M 3838
2019
Q3
$1.28M Sell
426,656
-151,200
-26% -$635K ﹤0.01% 2378
2019
Q2
$2.16M Sell
577,856
-267,700
-32% -$1.05M ﹤0.01% 2308
2019
Q1
$3.4M Sell
845,556
-195,700
-19% -$826K ﹤0.01% 2181
2018
Q4
$3.82M Sell
1,041,256
-977,556
-48% -$6.67M ﹤0.01% 2120
2018
Q3
$17.3M Sell
2,018,812
-459,485
-19% -$4.59M ﹤0.01% 1737
2018
Q2
$27.2M Sell
2,478,297
-73,823
-3% -$824K ﹤0.01% 1579
2018
Q1
$29.4M Buy
2,552,120
+1,276,470
+100% +$12.1M ﹤0.01% 1539
2017
Q4
$13.2M Buy
1,275,650
+421,139
+49% +$5.39M ﹤0.01% 1864
2017
Q3
$13.6M Sell
854,511
-196,100
-19% -$2.71M ﹤0.01% 1835
2017
Q2
$12.7M Sell
1,050,611
-1,072,495
-51% -$11.4M ﹤0.01% 1856
2017
Q1
$44.1M Sell
2,123,106
-179,391
-8% -$2.81M 0.01% 1367
2016
Q4
$32.9M Buy
2,302,497
+1,272,697
+124% +$19.4M ﹤0.01% 1485
2016
Q3
$16.9M Sell
1,029,800
-1,281,497
-55% -$18.5M ﹤0.01% 1755
2016
Q2
$33M Buy
2,311,297
+116,500
+5% +$1.57M ﹤0.01% 1452
2016
Q1
$31.8M Buy
+2,194,797
New +$31.5M ﹤0.01% 1444

Other funds holding CRVS